Circulation: Cardiovascular Interventions

DECEMBER 16, 2024

Circulation: Cardiovascular Interventions, Volume 17, Issue 12 , Page e014891, December 1, 2024.

TAVR 40

TAVR Cardiovascular Interventions Circulation 40

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013238, November 1, 2023. BACKGROUND:Coronary accessibility following redo–transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients.

TAVR 40

TAVR Aortic valve Anatomy Cardiovascular Interventions 40

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013571, November 1, 2023.

Aortic valve 40

Aortic valve TAVR Cardiovascular Interventions Aortic 40

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013572, November 1, 2023.

TAVR 40

TAVR Cardiovascular Interventions Circulation 40

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e012966, November 1, 2023. Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients.

Aortic valve 40

Aortic valve Aortic TAVR Heart Valves 40

Circulation: Cardiovascular Interventions

JANUARY 18, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Frailty associates with worse outcomes after transcatheter aortic valve replacement (TAVR). Cross-sectional muscle (psoas and paraspinal) areas were measured on computed tomography and indexed to height. m/s decrease [95% CI, 1.04–1.21];P=0.004;

Aortic valve 40

Aortic valve Aortic TAVR Stenosis 40

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Exposure of interest was PVD. Primary outcome was all-cause mortality.

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40